Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- PGF2a cPLA2i 1.0 BCD110605C16 0.164 pmol/ml of medium
- PGF2a cPLA2i 1.0 BCD110605C18 0.186 pmol/ml of medium
- PGF2a cPLA2i 1.0 BCD110605C17 0.067 pmol/ml of medium
- PGF2a cPLA2i 4.0 BCD110605C34 0.175 pmol/ml of medium
- PGF2a cPLA2i 4.0 BCD110605C36 0.475 pmol/ml of medium
- PGF2a cPLA2i 4.0 BCD110605C35 0.171 pmol/ml of medium
- PGF2a cPLA2i 20.0 BCD110605C53 0.34 pmol/ml of medium
- PGF2a cPLA2i 20.0 BCD110605C54 0.353 pmol/ml of medium
- PGF2a cPLA2i 20.0 BCD110605C52 0.466 pmol/ml of medium
- PGF2a PLDi 1.0 BCD110605C10 0.272 pmol/ml of medium
- PGF2a PLDi 1.0 BCD110605C12 0.226 pmol/ml of medium
- PGF2a PLDi 1.0 BCD110605C11 0.255 pmol/ml of medium
- PGF2a PLDi 4.0 BCD110605C30 0.218 pmol/ml of medium
- PGF2a PLDi 4.0 BCD110605C29 0.263 pmol/ml of medium
- PGF2a PLDi 4.0 BCD110605C28 0.361 pmol/ml of medium
- PGF2a PLDi 20.0 BCD110605C48 0.369 pmol/ml of medium
- PGF2a PLDi 20.0 BCD110605C47 0.288 pmol/ml of medium
- PGF2a PLDi 20.0 BCD110605C46 0.201 pmol/ml of medium
- PGF2a KDO+cPLA2i 1.0 BCD110605C19 0.239 pmol/ml of medium
- PGF2a KDO+cPLA2i 1.0 BCD110605C21 0.084 pmol/ml of medium
- PGF2a KDO+cPLA2i 1.0 BCD110605C20 0.092 pmol/ml of medium
- PGF2a KDO+cPLA2i 4.0 BCD110605C39 0.142 pmol/ml of medium
- PGF2a KDO+cPLA2i 4.0 BCD110605C37 0.334 pmol/ml of medium
- PGF2a KDO+cPLA2i 4.0 BCD110605C38 0.341 pmol/ml of medium
- PGF2a KDO+cPLA2i 20.0 BCD110605C55 0.692 pmol/ml of medium
- PGF2a KDO+cPLA2i 20.0 BCD110605C57 0.958 pmol/ml of medium
- PGF2a KDO+cPLA2i 20.0 BCD110605C56 0.689 pmol/ml of medium
- PGF2a KDO+PLDi 1.0 BCD110605C15 0.145 pmol/ml of medium
- PGF2a KDO+PLDi 1.0 BCD110605C14 0.33 pmol/ml of medium
- PGF2a KDO+PLDi 1.0 BCD110605C13 0.229 pmol/ml of medium
- PGF2a KDO+PLDi 4.0 BCD110605C32 0.497 pmol/ml of medium
- PGF2a KDO+PLDi 4.0 BCD110605C31 0.441 pmol/ml of medium
- PGF2a KDO+PLDi 4.0 BCD110605C33 0.495 pmol/ml of medium
- PGF2a KDO+PLDi 20.0 BCD110605C49 1.47 pmol/ml of medium
- PGF2a KDO+PLDi 20.0 BCD110605C51 1.12 pmol/ml of medium
- PGF2a KDO+PLDi 20.0 BCD110605C50 1.09 pmol/ml of medium
- PGF2a KDO + ATP 1.0 BCD110605C07 0.337 pmol/ml of medium
- PGF2a KDO + ATP 1.0 BCD110605C09 0.218 pmol/ml of medium
- PGF2a KDO + ATP 1.0 BCD110605C08 0.239 pmol/ml of medium
- PGF2a KDO + ATP 4.0 BCD110605C25 0.493 pmol/ml of medium
- PGF2a KDO + ATP 4.0 BCD110605C26 0.668 pmol/ml of medium
- PGF2a KDO + ATP 4.0 BCD110605C27 0.716 pmol/ml of medium
- PGF2a KDO + ATP 20.0 BCD110605C45 1.29 pmol/ml of medium
- PGF2a KDO + ATP 20.0 BCD110605C43 1.19 pmol/ml of medium
- PGF2a KDO + ATP 20.0 BCD110605C44 1.22 pmol/ml of medium
- PGF2a C 0.0 BCD110605C02 0.127 pmol/ml of medium
- PGF2a C 0.0 BCD110605C01 0.171 pmol/ml of medium
- PGF2a C 0.0 BCD110605C03 0.025 pmol/ml of medium
- PGF2a C 1.0 BCD110605C06 0.332 pmol/ml of medium
- PGF2a C 1.0 BCD110605C05 0.212 pmol/ml of medium